Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Milvexian in Healthy Chinese Adults
The pharmacokinetic, pharmacodynamic, and safety profiles of milvexian demonstrate suitability for further clinical development in Chinese participants.
Authors
- Xinchao Luo
- Tsung-I Lee
- Cuili Hu (ORCID: https://orcid.org/0000-0001-9308-9611)
- Peter Zannikos (ORCID: https://orcid.org/0000-0001-9444-3862)
- Zhuolu Niu
- Jie Wang (ORCID: https://orcid.org/0000-0003-4706-0302)
- Zhu Luo (ORCID: https://orcid.org/0000-0003-1030-2320)
- Madhu Chintala
- Alexei N. Plotnikov
Institutions
- Johnson & Johnson (United States) (US)
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
Publication Details
- Journal
- Drug Design Development and Therapy
- Published
- 2025-03-01
- DOI
- https://doi.org/10.2147/dddt.s488414
- Citations
- 4
- Primary Topic
- Healthcare and Venom Research
- Type
- article
- Field-Weighted Citation Impact
- 5.58